Apellis Pharmaceuticals, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Apellis Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2016 to Q3 2024.
  • Apellis Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $1.45M, a 23.4% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.45M +$275K +23.4% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $1.33M +$503K +60.8% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $1.31M +$520K +65.6% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.31M -$14.5M -91.7% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $1.18M -$14.6M -92.5% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $827K -$15.1M -94.8% Jun 30, 2023 10-Q 2023-07-31
Q1 2023 $793K -$15.2M -95% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $15.8M -$15.8M -50.1% Dec 31, 2022 10-K/A 2024-02-29
Q3 2022 $15.8M -$7.07M -31% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $15.9M -$215K -1.34% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $16M +$9.1M +132% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $31.6M +$12.8M +67.8% Dec 31, 2021 10-K 2023-02-21
Q3 2021 $22.8M +$21.9M +2411% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $16.1M +$15.2M +1677% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $6.91M +$6.06M +718% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $18.9M +$18.5M +4797% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $909K +$672K +284% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $906K +$698K +336% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $845K +$683K +420% Mar 31, 2020 10-Q 2020-04-29
Q4 2019 $385K +$269K +231% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $237K +$23.5K +11.1% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $208K +$91.7K +79% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $162K +$46.2K +39.8% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $116K +$270 +0.23% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $213K +$105K +96.6% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $116K Jun 30, 2018 10-Q 2018-07-31
Q1 2018 $116K Mar 31, 2018 10-Q 2018-04-30
Q4 2017 $116K +$51.6K +80% Dec 31, 2017 10-K 2019-02-26
Q3 2017 $108K Sep 30, 2017 10-Q 2017-12-20
Q4 2016 $64.5K Dec 31, 2016 10-K 2018-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.